Genetic Link Identified for Multiple Forms of Glaucoma

This article originally appeared here.
Share this content:
Genetic Link Identified for Multiple Forms of Glaucoma
Genetic Link Identified for Multiple Forms of Glaucoma

(HealthDay News) – Two genomic regions have been identified that are associated with normal-pressure glaucoma (NPG) and optic nerve disease in exfoliation-syndrome glaucoma (ESG), possibly through the transforming growth factor beta (TGF-beta) signaling pathway.

Janey L. Wiggs, MD, PhD, from the Massachusetts Eye and Ear Infirmary in Boston, and colleagues performed a meta-analysis using data from two independent genome-wide association studies for primary open angle glaucoma (POAG), including 3,146 cases and 3,487 controls, followed by subgroup analysis of NPG (defined by intraocular pressure of <22mmHg). The single-nucleotide polymorphisms that demonstrated the most significant associations were also tested for correlation with ESG.

In meta-analysis of the two POAG datasets, the researchers identified significant associations between two loci (the CDKN2BAS region on 9p21 [rs2157719] and the SIX1/SIX6 region on chromosome 14q23 [rs10483727]) and POAG (odds ratio [OR] for G and A allele, 0.69 and 1.32, respectively). In sub-group analysis, two loci (9p21 containing the CDKN2BAS gene [rs2157719] and a probable regulatory region on 8q22 [rs284489]) were significantly associated with NPG (OR for G and G allele, 0.58 and 0.62, respectively). Both NPG loci were also minimally associated with ESG (OR, 0.59 [P=0.004] and 0.76 [P=0.021], respectively). Both loci influenced TGF-beta signaling, and genomic pathway analysis indicated a correlation between TGF-beta and NPG.

"These results suggest that neuro-protective therapies targeting TGF-beta signaling could be effective for multiple forms of glaucoma," the authors write.

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs